Mikhail Blagosklonny: The Scientist behind Anti-Aging and Cancer Treatment Research
Aging is a process that most people in the world have accepted and made peace with it, apart from a few scientists who have strong conviction that this rather natural process cab be stopped. Cancer too is one of the biggest enemies of the human race, and has a big menace in the world today. But meeting Doctor Mikhail Blagosklonny and getting to read some of his research, a glimpse of hope will shine through the life of many people. Doctor Mikhail is an oncologist and a scientist who has a deep passion for studying cancer through cell division and trying to understand how aging could be related to cancer.
Doctor Mikhail got his education from the First Pavlov State Medical University of St. Petersburg where he got his master’s degree in internal medicine. He went further to get a Ph.D. in Cardiology as well as Experimental Medicine from the same institution. He has put the skills he learned to good use, especially on his hypothesis that claims that TOR signaling has a significant effect on aging and cancer. He suggests the use of Rapamycin, a drug that will help in controlling TOR signaling.
Mikhail is currently working at the Roswell Park Cancer Institute, which is one of the most reputable research institutes for cancer; he has worked here since 2009. He was appointed to work as a professor at this institute due to his extensive research on cancer. Mikhail had previously worked at the New York Medical College as an associate professor, then moved to work with Ordway Research Institute where he worked as a scientist with his research covering the topics of aging, cancer and targeted therapies for cancer among others broadly. Visit ResearchGate.Net to learn more about Mikhail’s latest work.
Mikhail Blagosklonny is recognized as the chief editor of Cell Cycle and Oncotarget. He has also written over 150 medical articles and journals. Mikhail stands as the chief editor in other publications related to cell division studies, anti-aging and cancer in general. He is a strong advocate of the use of Rapamycin drug in treating cancer due to his strong conviction after research that cell division and aging are related to cancer. View Mikhail’s profile in LinkedIn.